NFE2L2 and hepatocellular carcinoma: Apigenin and luteolin at their noncytotoxic concentrations activate the PI3K/NRF2/ARE intracellular pathway system and suppress LPS-induced NO, iNOS, and cPLA2 in human hepatoma HepG2 cells, thereby exerting anti-inflammatory potential [81].